scispace - formally typeset
M

Masahide Hamaguchi

Researcher at Kyoto Prefectural University of Medicine

Publications -  252
Citations -  10119

Masahide Hamaguchi is an academic researcher from Kyoto Prefectural University of Medicine. The author has contributed to research in topics: Medicine & Type 2 diabetes. The author has an hindex of 31, co-authored 197 publications receiving 7643 citations. Previous affiliations of Masahide Hamaguchi include Texas A&M University & Asahi University.

Papers
More filters
Journal ArticleDOI

A promoter-level mammalian expression atlas

Alistair R. R. Forrest, +280 more
- 27 Mar 2014 - 
TL;DR: For example, the authors mapped transcription start sites (TSSs) and their usage in human and mouse primary cells, cell lines and tissues to produce a comprehensive overview of mammalian gene expression across the human body.
Journal ArticleDOI

The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

TL;DR: Evaluated the cross-sectional relationship between the metabolic syndrome, defined by the modified ATP III criteria, and the prevalence of nonalcoholic fatty liver disease in Japanese persons and addressed longitudinal aspects of the disease and its development and regression.
Journal ArticleDOI

The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.

TL;DR: The scoring system with abdominal ultrasonography could provide accurate information about hepatic steatosis, visceral obesity, and the metabolic syndrome in apparently healthy people who do not consume alcohol.
Journal ArticleDOI

T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Development

TL;DR: It is shown that Treg cell development was achieved by the combination of two independent processes, i.e., the expression of Foxp3 and the establishment of TReg cell-specific CpG hypomethylation pattern, and those T cells in which the two events have concurrently occurred are developmentally set into the T Reg cell lineage.
Journal ArticleDOI

Two FOXP3 + CD4 + T cell subpopulations distinctly control the prognosis of colorectal cancers

TL;DR: Depletion of FOXP3hi Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population ofFOXP3lo non-Treg cells could be used to suppress or prevent tumor formation.